ArticleInternational journal of nanomedicine2025
Multimodal Imaging of Brain Metastasis-Derived Extracellular Vesicles Using Superparamagnetic Iron Oxide Nanoparticle Labeling.
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An updated review on the role of extracellular vesicles in immune system modulation in breast cancer with special emphasis on immune checkpoint regulators.Frontiers in immunology · 2026Review
- The Norway-Japan bilateral symposium: Dialogue in biophysics beginning in Nara.Biophysics and physicobiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Extracellular vesicles (EVs) are crucial mediators in brain metastasis (BM), facilitating pre-metastatic niche formation and metastatic progression. However, tracking their distribution and interactions in vivo remains challenging. Objective: To develop and validate a method for labeling BM-derived EVs using superparamagnetic iron oxide nanoparticles (SPIONs) that enables their visualization and tracking through magnetic resonance imaging (MRI). Methods: Three SPION variants with different coatings and sizes were evaluated using two patient-derived BM cell lines. The labeled EVs were characterized using transmission electron microscopy (TEM), colorimetric iron assays, dynamic light scattering and nanoparticle tracking analysis (NTA) in Nanospacer devices. The functionality and visualization of SPION-labeled EVs were assessed in fetal rat brain organoids (FRBOs) using Prussian blue staining, TEM, and MRI. Detection sensitivity was determined using agar phantoms, and in vivo tracking was validated through intramuscular injections in mice. Results: Uncoated 5 nm SPIONs demonstrated superior labeling efficiency, successfully marking over 90% of cells within 24 hours without significantly affecting cell growth. These SPIONs were effectively incorporated into BM-derived EVs while maintaining their original size distribution. The labeled EVs were successfully internalized by FRBOs and could be visualized using multiple imaging modalities. Agar phantom studies revealed significant changes in T2 and T2* relaxation times, which was further confirmed through in vivo MRI following intramuscular injections. Conclusion: This study establishes a reliable protocol for labeling BM-derived EVs with SPIONs, enabling their visualization across various biological contexts, from subcellular to tissue levels. This proposed model facilitates a valuable tool for spatially tracking BM-EVs in vivo, identifying specific target cells, and investigating their functional role in metastatic progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.